... the epidermalgrowthfactor receptor (EGFR) has emerged as a primary strategy, although not much information is available about these therapies in HPV-positive ...
... are growthfactor receptors, and especially the epidermalgrowthfactor receptor family member 1 (EGFR, also known as HER1 or ...this growth fac- tor receptor, conferring it with ...
... migration, and vascular tone control (6, 7, 9, 19 –23), EGF is also a key regulator in a variety of cellular systems. It binds to EGFR, triggering tyrosine kinase activity that results in the activation of several ...
... cell growth, survival and spread are enhanced and those of genes that suppress these effects are ...evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, ...
... Podemos considerar, por tanto, que en la actualidad no existe una profilaxis estándar dermatológica única reconocida (7;8) . Se han utilizado diversos productos a base de urea, aloe vera, caléndula entre otros principios ...
... 1. Fernandez - Montequín JL, Valenzuela Silva CM, Diaz OG, et al. Intra-lesional injections of recombinant human epidermalgrowthfactor promote granulation and healing in advanced diabetic foot ...
... encode growth receptors and growth ...and epidermalgrowthfactor receptor (EGFR) are ...genesis, growth, and survival of a subgroup of oral premalignant lesions could depend on ...
... man epidermalgrowthfactor receptor-2 (HER2) pos- itive and the triple-negative breast cancer (TNBC), characterized by the lack of expression of estrogen receptor (ER), progesterone receptor, and ...
... Epidermalgrowthfactor (EGF) and its receptor EGFR are believed to be important in the control of ...other growth factors, may lead to prolonged survival especially for those patients with ...
... 27. Tsang M, Tsang K.Y, Keung W, Wong R. “The use of recombinant human epidermalgrowthfactor (Rh EGF ) in a gentleman with drug-in- duced Steven Johnson Syndrome”. Dermatol Online J 2004; 10. 28. ...
... Recent evidences suggest that neurogenesis could occur in different zones of the central nervous system. Objective: with the purpose of analyzing neurogenesis, we have done a study in the arcuate nucleus of hypothalamus ...
... insulin, epidermalgrowthfactor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary ...
... human epidermalgrowthfactor receptor 2 (HEr2), an oncogenic member of the EgFr family, which leads to abnormal ligand-induced ubiquitination and receptor ...
... ABSTRACT Nimotuzumab, efficacious immunotherapy against epithelial malignant tumors. Nimotuzumab is a huma- nized monoclonal, new biotechnology drug against the epidermalgrowthfactor receptor that ...
... The definition of the genomic intrinsic subtypes of breast cancer has been established as the best explan- ation for the heterogeneous patient outcomes [1-3]. In their original paper, Perou et al. [1] found that the ...
... Tumor doubling time values and survival curves indi- cate that the EL and ES phases differ in CBi/L line from those observed in CBi and CBi − mice. Interestingly, both processes lasted more in CBi/L than in CBi and CBi − ...
... insulin-like growthfactor can be more important to produce an activation of the pathway than the mere presence of an increased amount of receptors ...
... products shows a statistically significant decrease in wrinkles and fine lines along with an increase in Grenz zone collagen and epidermal thickness after topical application to Fitzpatrick skin types II and ...
... chemokines, growth-regulating molecules, and metalloproteinases and other hydrolytic ...colony-stimulating factor and granulocyte–macrophage colony-stimulating factor for monocytes and interleukin-2 ...